Neurology Central

Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma multiforme may predict improved survival


Aims: This retrospective study determined the survival of glioblastoma patients with or without pseudoprogression. Methods: A total of 68 patients were included. Overall survival was compared between patients showing pseudoprogression (in most cases diagnosed using perfusion MRI with ferumoxytol) and in patients without pseudoprogession. MGMT methylation status was also analyzed in the pseudoprogression cases.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Click here to read the full article